Bruker Corp (BRKR) stock
BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30293% above fair value
$60.62−0.97 (-1.57%)
Close on Nov 16, 2026Market cap $9.40BP/E –Yield –
Bruker ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Bruker's ebitda for the twelve months ending Jun 30, 2026 was $199.50M, down 49.4% year over year. For fiscal 2025 it was $288.50M, down 34.0% from the year before. Over ten years it grew 3.8% a year on average. The highest annual figure on record is $551.80M in fiscal 2023.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $288.50M | -34.0% |
| FY2024 | Dec 31, 2024 | $436.90M | -20.8% |
| FY2023 | Dec 31, 2023 | $551.80M | +5.8% |
| FY2022 | Dec 31, 2022 | $521.50M | +3.8% |
| FY2021 | Dec 31, 2021 | $502.40M | +52.8% |
| FY2020 | Dec 31, 2020 | $328.70M | -12.7% |
| FY2019 | Dec 31, 2019 | $376.50M | +15.0% |
| FY2018 | Dec 31, 2018 | $327.30M | +15.5% |
| FY2017 | Dec 31, 2017 | $283.40M | +20.0% |
| FY2016 | Dec 31, 2016 | $236.10M | +18.6% |
| FY2015 | Dec 31, 2015 | $199.00M | +20.5% |
| FY2014 | Dec 31, 2014 | $165.10M | -21.2% |
| FY2013 | Dec 31, 2013 | $209.50M | -2.6% |
| FY2012 | Dec 31, 2012 | $215.10M | +3.2% |
| FY2011 | Dec 31, 2011 | $208.50M | +8.7% |
| FY2010 | Dec 31, 2010 | $191.80M | +15.3% |
| FY2009 | Dec 31, 2009 | $166.40M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.30M | -110.7% |
| Q1 FY2026 | Mar 31, 2026 | $68.50M | -16.7% |
| Q4 FY2025 | Dec 31, 2025 | $134.40M | +7.5% |
| Q3 FY2025 | Sep 30, 2025 | $3.90M | -96.7% |
| Q2 FY2025 | Jun 30, 2025 | $68.00M | -27.0% |
| Q1 FY2025 | Mar 31, 2025 | $82.20M | -17.4% |
| Q4 FY2024 | Dec 31, 2024 | $125.00M | -11.2% |
| Q3 FY2024 | Sep 30, 2024 | $119.10M | -21.2% |
| Q2 FY2024 | Jun 30, 2024 | $93.20M | -16.9% |
| Q1 FY2024 | Mar 31, 2024 | $99.50M | -32.7% |
| Q4 FY2023 | Dec 31, 2023 | $140.80M | -9.5% |
| Q3 FY2023 | Sep 30, 2023 | $151.10M | -0.8% |
| Q2 FY2023 | Jun 30, 2023 | $112.10M | +17.4% |
| Q1 FY2023 | Mar 31, 2023 | $147.80M | +25.0% |
| Q4 FY2022 | Dec 31, 2022 | $155.50M | +4.8% |
| Q3 FY2022 | Sep 30, 2022 | $152.30M | +12.5% |
| Q2 FY2022 | Jun 30, 2022 | $95.50M | -10.9% |
| Q1 FY2022 | Mar 31, 2022 | $118.20M | +6.1% |
| Q4 FY2021 | Dec 31, 2021 | $148.40M | +10.3% |
| Q3 FY2021 | Sep 30, 2021 | $135.40M | +33.1% |
| Q2 FY2021 | Jun 30, 2021 | $107.20M | +87.7% |
| Q1 FY2021 | Mar 31, 2021 | $111.40M | +214.7% |
| Q4 FY2020 | Dec 31, 2020 | $134.50M | -1.1% |
| Q3 FY2020 | Sep 30, 2020 | $101.70M | -4.7% |
| Q2 FY2020 | Jun 30, 2020 | $57.10M | -21.7% |
| Q1 FY2020 | Mar 31, 2020 | $35.40M | -41.9% |
| Q4 FY2019 | Dec 31, 2019 | $136.00M | +10.6% |
| Q3 FY2019 | Sep 30, 2019 | $106.70M | +25.5% |
| Q2 FY2019 | Jun 30, 2019 | $72.90M | +11.5% |
| Q1 FY2019 | Mar 31, 2019 | $60.90M | +13.0% |
| Q4 FY2018 | Dec 31, 2018 | $123.00M | +10.8% |
| Q3 FY2018 | Sep 30, 2018 | $85.00M | +24.3% |
| Q2 FY2018 | Jun 30, 2018 | $65.40M | +27.5% |
| Q1 FY2018 | Mar 31, 2018 | $53.90M | +2.3% |
| Q4 FY2017 | Dec 31, 2017 | $111.00M | +22.2% |
| Q3 FY2017 | Sep 30, 2017 | $68.40M | +14.8% |
| Q2 FY2017 | Jun 30, 2017 | $51.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $52.70M | – |
| Q4 FY2016 | Dec 31, 2016 | $90.80M | – |
| Q3 FY2016 | Sep 30, 2016 | $59.60M | – |
See a number that looks wrong?